In a significant breakthrough for oncology and molecular biology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel Cancer…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
At its recent annual Science Day, biotechnology giant Moderna signaled a profound strategic expansion beyond its highly successful infectious disease…
Read More
Fungal gene editing world-first points to promising cancer medicines
A groundbreaking development from the University of Pennsylvania (PA, USA) has introduced a sophisticated gene-editing platform, fPE7max, specifically optimized for…
Read More
Unlocking Nature’s Pharmacy: Scientists Decipher Bacterial Secrets to Multi-Drug Cancer Therapies
For decades, the intricate molecular dance within bacteria that yields a remarkable array of potent anti-cancer compounds remained an enigma,…
Read More
Exploring the Cutting Edge: New eBook Dives into Single-Cell Spatial Omics, Cancer, Neurodevelopmental Diseases, and AI in Biomedical Research
The newly released eBook, supported by Takara Bio, offers an in-depth exploration into the revolutionary advancements shaping the field of…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Driving Rare Kidney Cancer Progression through Liquid Protein Droplets
In a significant advancement for the field of precision oncology, a multidisciplinary team of investigators from the Johns Hopkins Kimmel…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
Moderna, the biotechnology firm that gained global prominence for its mRNA-based COVID-19 vaccine, is embarking on a significant strategic pivot,…
Read More
Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
Acute Myelogenous Leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by a rapid progression and…
Read More
Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026
The biotech sector is experiencing a robust resurgence, marked by significant investment, strategic mergers and acquisitions, and groundbreaking clinical advancements,…
Read More
Breakthrough in Rare Kidney Cancer Research Reveals How Gene Fusions Drive Tumor Progression via Liquid Condensates
In a significant advancement for the field of molecular oncology, a multi-disciplinary team of investigators from the Johns Hopkins Kimmel…
Read MoreYOU MAY HAVE MISSED
